A Search for Predictive Factors for Hypersensitivity Reactions to Paclitaxel and Platinum Salts in Chemotherapy for Gynecologic Pelvic Neoplasms

Publisher： Karger

E-ISSN： 1423-002x|74|1|21-27

ISSN： 0378-7346

Source： Gynecologic and Obstetric Investigation, Vol.74, Iss.1, 2012-05, pp. : 21-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimal Debulking Surgery Followed by Paclitaxel/Platinum Chemotherapy Is Very Effective in Treating Ovarian Carcinosarcomas: A Single Center Experience

By  

Gynecologic and Obstetric Investigation, Vol. 72, Iss. 3, 2011-09 ,pp. : 208-214

Karger

Access to resources Recommend Favorite

Pilot Phase 2 Trial of 4 Months of Maintenance Pegylated Liposomal Doxorubicin in Patients with Advanced Ovarian Cancer after Complete Response to Platinum and Paclitaxel-Based Chemotherapy

By  

Gynecologic and Obstetric Investigation, Vol. 63, Iss. 1, 2006-06 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Feasibility Study on Biweekly Paclitaxel Treatment as Maintenance Chemotherapy in Advanced Müllerian Carcinoma

By  

Gynecologic and Obstetric Investigation, Vol. 73, Iss. 4, 2012-03 ,pp. : 272-276

Karger

Access to resources Recommend Favorite

Predictive Markers of Tubo-Ovarian Abscess in Pelvic Inflammatory Disease

By  

Gynecologic and Obstetric Investigation, Vol. 81, Iss. 2, 2015-04 ,pp. : 97-104

Karger

Access to resources Recommend Favorite

Risk Factors for the Recurrence of Pelvic Organ Prolapse

By  

Gynecologic and Obstetric Investigation, Vol. 66, Iss. 4, 2008-08 ,pp. : 268-273

Karger

Access to resources Recommend Favorite